2022
DOI: 10.2147/jmdh.s341130
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 Pandemic Disruption on the Management of Tuberculosis Treatment in Indonesia

Abstract: The current coronavirus disease 2019 (COVID-19) situation might deteriorate the efforts to eliminate tuberculosis (TB) in Indonesia. This study aimed to review the COVID-19 pandemic disruption on the management of TB treatment in Indonesia. We identified several disruptions due to the pandemic on TB control management. Firstly, there is a potential decrease in the funding for TB treatment. Financial disruptions caused by the COVID-19 pandemic have led to further setbacks. In many countries, including Indonesia… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
24
0
3

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 35 publications
(32 citation statements)
references
References 18 publications
3
24
0
3
Order By: Relevance
“…Factors found to be associated with poor treatment outcomes during the pandemic were similar to what other studies have already described (age ≥45, having HIV, case finding site at a facility, having a clinical diagnosis without a bacteriologically confirmed result, and an existing comorbidity of diabetes or hypertension) [12,28,30]. Older age, being HIV positive and having an existing comorbidity were found to be factors mostly associated with death as an outcome among TB patients treated during the pandemic [17,34].…”
Section: Discussionsupporting
confidence: 81%
“…Factors found to be associated with poor treatment outcomes during the pandemic were similar to what other studies have already described (age ≥45, having HIV, case finding site at a facility, having a clinical diagnosis without a bacteriologically confirmed result, and an existing comorbidity of diabetes or hypertension) [12,28,30]. Older age, being HIV positive and having an existing comorbidity were found to be factors mostly associated with death as an outcome among TB patients treated during the pandemic [17,34].…”
Section: Discussionsupporting
confidence: 81%
“…'TB CEPAT', an active case finding initiative that conducted door-todoor symptom screening in 2016-2017, is likely to have contributed to increased TB [20][21][22]. Damaging impacts of the COVID-19 pandemic on TB program performance have been reported nationally and internationally [1,23]. Indonesian national TB case notifications dropped to 393,323 in 2020, a 31% reduction compared to 2019 and less than half the estimated caseload.…”
Section: Discussionmentioning
confidence: 99%
“…However, their compliance did gradually dwindle over time owing to an increase in the number of COVID-19 cases. This was mirrored in many other countries where the level of tuberculosis care decreased due to the burden of COVID-19 [ 8 , 16 , 17 ].…”
Section: Discussionmentioning
confidence: 94%